4-(Piperidin-3-yl)aniline

4-(Piperidin-3-yl)aniline

Intermediate for Niraparib. Niraparib (trade name Zejula) is an orally active small molecule PARP inhibitor developed by Tesaro to treat ovarian cancer. Niraparib has been approved by US FDA on March27, 2017.

Specifications

Product Name:                  4-(Piperidin-3-yl)aniline

Synonyms:                         N/A

CAS Number:                     19733-56-3

Molecular Weight:            176.2608

Molecular Formula:          C11H16N2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               NC1=CC=C(C2CNCCC2)C=C1

  • $3,877.00
  • Ex Tax: $3,877.00

Available Options